Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. American companies and academic institutions possess unique competitive advantages in developing these global leaders.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

MARCH 11, 2014

That is, why bother trying to innovate if no matter what they do, large companies can no longer maintain a sustainable advantage and their life spans are just getting shorter and shorter? In these markets if existing companies don’t rise to the innovation challenge, no one will. “Why bother?”.

Innovation 8

Innovation Venture Capitalist Company Supply Chain 8

Harvard Business Review

OCTOBER 1, 2014

The implicit axiom here is that robust companies that have sustained and grown over the longer term are somehow less innovative. And Alibaba is a 16 year-old company, and no one is claiming it is sluggish or un-innovative.) But wait a minute – is starting more new businesses always a good thing?

Entrepreneur 10

Entrepreneur Biotechnology Real Estate Innovation 10

Harvard Business Review

OCTOBER 26, 2011

Their behavior displays promising parallels to the early days of the biotechnology industry. When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive. Click on the table below to see at full size.).

Energy 11

Energy Finance IPO Biotechnology 11

Strategy Driven

NOVEMBER 18, 2019

Globally, the energy sector is valued in excess of $7 trillion and by 2035 it is anticipated that the global demand for energy will increase by as much as 30%. This increased the need for care items for the elderly and there are plenty of gaps in the market for the healthcare sector. Technology.

Health Care 67

Health Care Biotechnology Energy Insurance 67

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Finding ideas is never the problem — initially. Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

JUNE 16, 2016

To understand the nature of the problem, let’s look at how penicillin was brought to market. The Institute for Applied Cancer Science at MD Anderson (IACS) is exploring revolutionary new cures and the National Network for Manufacturing Innovation (NNMI) is working to revive the US production capacity. The Valley of Death.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. The positions are there for the taking. But not for long. The options are tangible.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

MARCH 13, 2012

And of course that's true — but the commodities market has been booming only in recent years, and the bank's track record is long and impressive. Is it possible that local funding could help bolster tourism in Florida, biotechnology in California, publishing in New York, and agriculture in Iowa?

Biotechnology 10

Biotechnology Real Estate Tourism Banking 10

Harvard Business Review

FEBRUARY 3, 2015

Make you more innovative. For example, recently we were in a meeting discussing the results of a global people survey. Uzzi and another colleague, Jarrett Spiro, also discovered that this pattern held across sectors as disparate as the Broadway mu­sical industry and biotechnology. Learn more about your market value.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

NOVEMBER 29, 2016

It will increasingly help government health agencies, payers, and providers to make decisions about such issues as drug discovery, patient access, and marketing. Innovating for Value in Health Care. Insight Center. Sponsored by Medtronic. Exploring cutting edge ways to lower costs and improve quality.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

JUNE 12, 2012

trillion in government support for seven "strategic emerging industries," including alternative energy, biotechnology, next-gen IT, high-end manufacturing equipment, and advanced materials. The United States is home to some of the key pioneers of Technik whose innovations help society adapt to the future. It pledges $1.5

First-mover Advantage 9

First-mover Advantage GDP Technology Biotechnology 9

Harvard Business Review

NOVEMBER 9, 2016

While it’s understandable that stock and currency markets would react this way to the outcome of the election, I believe that it’s somewhat of an overreaction. That’s how they climb the global value chain. Mexico’s economy was going to have to enter into a new era regardless of who became the next U.S.

Cooper 13

Cooper Long-term Industry Health Care 13